Fardous F El-Senduny

10PUBLICATIONS
34CO-AUTHORS
Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationshipsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 13, 2023
Design, biological evaluation, and molecular modelling insights of cupressic acid derivatives as promising anti-inflammatory agents.

Amal F Soliman, Diaaeldin M Elimam, Fardous F El-Senduny

|Jun 24, 2022
Rapamycin Improves Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Renoprotective Effect against Cisplatin-Induced Acute Nephrotoxicity in Rats by Inhibiting the mTOR/AKT Signaling Pathway.

Amira Awadalla, Abdelaziz M Hussein, Yousra M El-Far

|Jun 01, 2022
Synthesis of new thienylnicotinamidines: Proapoptotic profile and cell cycle arrest of HepG2 cells.

Mohamed A Ismail, Ghada A Abdelwahab, Wafaa S Hamama

|May 11, 2022
Substituted spirooxindole derivatives as potent anticancer agents through inhibition of phosphodiesterase 1.

Assem Barakat, Mohammad Shahidul Islam, Hussien Mansur Ghawas

|Feb 26, 2022
Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition.

Mater H Mahnashi, Fardous F El-Senduny, Mohammed Abdulrahman Alshahrani

|Aug 24, 2021
Urea-functionalized organoselenium compounds as promising anti-HepG2 and apoptosis-inducing agents.

Fardous F El-Senduny, Sameh M Shabana, Daniel Rösel

Pageof 2

Frequent Collaborators

3 joint publications

Assem Barakat

3 joint publications

Mohammad Shahidul Islam

2 joint publications

Farid A Badria

1 joint publications

Shirin Assar